Success Story: NIW Approved Without RFE For a Chinese Associate Research Scientist Thanks to Our Guidance
Client’s Testimonial:
“I had an excellent experience working with the team on my NIW petition. They provided clear guidance from the beginning, helping me understand the requirements and organize my materials effectively. Their expertise in drafting my personal statement, compiling supporting evidence, and shaping the overall strategy made the entire process smooth and manageable. I truly appreciate their professionalism, responsiveness, and attention to detail. Thanks to their support, I felt confident at every step and ultimately submitted a strong application.”
On November 19th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: November 19th, 2025
Processing Time: 21 months, 27 days
Case Summary:
Our firm is pleased to share the approval of an EB-2 National Interest Waiver (NIW) petition for a molecular biology researcher whose work is advancing the understanding and treatment of critical urinary tract diseases. Drawing on NAILG’s extensive experience and proven NIW strategy, our team prepared a detailed petition that clearly demonstrated the national importance of the client’s research and the client’s strong record of success in this highly specialized area. The petition was approved, allowing the client to continue this impactful work in the United States.
Research Impact and National Significance
With a Ph.D. in Biochemistry and Molecular Biology, the client has established expertise in molecular mechanisms of disease, particularly those affecting the urinary tract. The client’s proposed endeavor focuses on developing a state-of-the-art approach to investigate the molecular pathogenesis of serious urinary tract conditions. By identifying how key genes and pathways drive disease progression, the client’s research supports the creation of more precise diagnostics and more effective therapies for disorders such as severe urinary tract infections and aggressive bladder diseases.
Urinary tract diseases impose a heavy burden on public health in the United States, with recurring infections and related conditions contributing to high medical costs and reduced quality of life. The petition highlighted that the client’s research directly addresses this nationwide challenge by enabling earlier detection, improved risk prediction, and better treatment approaches. This clear public health value supported our argument that the endeavor has substantial merit and national importance.
Impressive Research Record
The client has built a strong publication portfolio that demonstrates sustained influence in molecular biology and disease research. The record includes 15 peer-reviewed journal articles (including 2 as first author and 1 as co-first author) and 3 abstracts. The client’s work has been cited 541 times, reflecting broad reliance on these findings by independent researchers worldwide.
In the petition, NAILG emphasized that multiple studies rank among the most highly cited papers in molecular biology and genetics for their publication years, showing that the client’s discoveries are not only original but also widely adopted in ongoing research. This level of scientific attention is a strong indicator of fieldwide impact and leadership.
Expert Endorsements
To strengthen the NIW filing, NAILG submitted four letters of recommendation from distinguished experts in molecular biology, urology, and disease pathogenesis. These letters confirmed the originality of the client’s work and emphasized the importance of continuing this research in the United States.
“Through outstanding publications on urinary disease mechanisms and extensive peer review work, [Client] has dispelled any doubt as to his scientific leadership in his field. His observations have propelled him to the forefront of molecular biology research, earning him the opportunity to continue working in the United States.”
NIW Approval and Outlook
USCIS approved the NIW petition after recognizing the national relevance of the client’s research and the client’s established ability to advance this endeavor. This approval allows the client to continue developing cutting-edge molecular approaches that improve the diagnosis and treatment of urinary tract diseases, ultimately reducing disease burden and healthcare costs for patients across the country.
NAILG is honored to have represented the client in this successful NIW case and looks forward to the continued contributions the client will make to biomedical discovery and public health advancement in the United States.